These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 216767)
1. Naturally occurring lymphocyte-mediated immunity to endogenous type-C virus in the mouse. Blocking of the lymphocyte reactivity with antisera to the virus. Kende M; Hill R; Dinowitz M; Stephenson JR; Kelloff GJ J Exp Med; 1979 Feb; 149(2):358-71. PubMed ID: 216767 [TBL] [Abstract][Full Text] [Related]
2. Naturally occurring humoral immunity to endogenous xenotropic and amphotropic type-C virus in the mouse. Kende M; Veronese F; Hill DW; Dinowitz M; Kelloff GJ Int J Cancer; 1981 Feb; 27(2):235-42. PubMed ID: 6270013 [TBL] [Abstract][Full Text] [Related]
3. Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity. Ihle JN; Lazar B J Virol; 1977 Mar; 21(3):974-80. PubMed ID: 191656 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71. Lee JC; Ihle JN J Immunol; 1977 Mar; 118(3):928-34. PubMed ID: 191530 [TBL] [Abstract][Full Text] [Related]
5. Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses. Lee JC; Ihle JN J Natl Cancer Inst; 1975 Oct; 55(4):831-8. PubMed ID: 52718 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71. Lee JC; Ihle JN J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879 [TBL] [Abstract][Full Text] [Related]
7. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. Stephenson JR; Peters RL; Hino S; Donahoe RM; Long LK; Aaronson SA; Kelloff GJ J Virol; 1976 Sep; 19(3):890-8. PubMed ID: 184303 [TBL] [Abstract][Full Text] [Related]
8. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice. Kelloff GJ; Peters RL; Donahoe RM; Ghazzouli I; Sass B; Nims RM; Huebner RJ Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922 [TBL] [Abstract][Full Text] [Related]
9. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus. Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539 [TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice. Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223 [TBL] [Abstract][Full Text] [Related]
11. Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus. Shinohara N; Sachs DH J Exp Med; 1979 Sep; 150(3):432-44. PubMed ID: 113478 [TBL] [Abstract][Full Text] [Related]
12. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens. Hanna MG; Ihle JN; Lee JC Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222 [TBL] [Abstract][Full Text] [Related]
13. Association of mouse major histocompatibility and Rauscher murine leukaemia virus envelope glycoprotein antigens on leukaemia cells and their recognition by syngeneic virus-immune-cytotoxic T-lymphocytes. Zarling DA; Keshet I; Watson A; Bach FH Scand J Immunol; 1978; 8(6):497-508. PubMed ID: 83670 [TBL] [Abstract][Full Text] [Related]
14. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Barbacid M; Bolognesi D; Aaronson SA Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1617-21. PubMed ID: 6154936 [TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. Peters CJ; Theofilopoulos AN J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469 [TBL] [Abstract][Full Text] [Related]
16. Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates. Charman HP; Kim N; White M; Marquardt H; Gilden RV; Kawakami T J Natl Cancer Inst; 1975 Dec; 55(6):1419-24. PubMed ID: 173868 [TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to antigens associated with endogenous murine C-type leukemia viruses. Hirsch ME; Kelly AP; Proffitt MR; Black PH Science; 1975 Mar; 187(4180):959-61. PubMed ID: 167435 [TBL] [Abstract][Full Text] [Related]
18. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice. Lopez DM; Lopez PF; Parks WP; Paul RD J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214 [TBL] [Abstract][Full Text] [Related]